A Frameshift Variant in ANKRD24 Implicates Its Role in Human Non‐Syndromic Hearing Loss
Clinical Genetics · 2025
DOI: 10.1111/cge.14635 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, 2025. Verfasst von Negar Kazemi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Frameshift Mutation, Hearing Loss, Sensorineural, Genetic Predisposition to Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Hearing loss (HL) is the most prevalent sensorineural disorders, affecting about one in 1000 newborns. Over half of the cases are attributed to genetic factors; however, due to the extensive clinical and genetic heterogeneity, many cases remain without a conclusive genetic diagnosis. The advent of next‐generation sequencing methodologies in recent years has greatly helped unravel the genetic etiology of HL by identifying numerous genes and causative variants. Despite this, much remains to be uncovered about the genetic basis of sensorineural hearing loss (SNHL). Here, we report an Iranian consanguineous family with postlingual, moderate‐to‐severe autosomal recessive SNHL. After first excluding plausible variants in known deafness‐causing genes using whole exome sequencing, we reanalyzed the data, using a gene/variant prioritization pipeline established for novel gene discovery for HL. This approach identified a novel homozygous frameshift variant c.1934_1937del; (p.Thr645Lysfs*52) in ANKRD24 , which segregated with the HL phenotype in the family. Recently, ANKRD24 has been shown to be a pivotal constituent of the stereocilia rootlet in cochlea hair cells and interacts with TRIOBP, a protein already implicated in human deafness. Our data implicate for the first time, ANKRD24 in human nonsyndromic HL (NSHL) and expands the genetic spectrum of HL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
- Department of Bioinformatics, Genoks Genetic Diagnosis Center, Ankara, Turkey.
- Ilyome Bioinformatics, Ankara, Turkey.
- Department of Medical & Molecular Genetics, Indiana University, Indianapolis, Indiana, USA.
- Department of Otolaryngology, Head & Neck Surgery, Indiana University, Indianapolis, Indiana, USA.
ORCID-Profile: Masoud Edizadeh, Kimia Kahrizi, Hossein Najmabadi, Marzieh Mohseni
Zitieren
APA
Kazemi, N., Rezvani Rezvandeh, R., Zare Ashrafi, F., Shokouhian, E., Edizadeh, M., Booth, K. T. A., Kahrizi, K., Najmabadi, H., & Mohseni, M. (2025). A Frameshift Variant in ANKRD24 Implicates Its Role in Human Non‐Syndromic Hearing Loss. Clinical Genetics. https://doi.org/10.1111/cge.14635
Vancouver
Kazemi N, Rezvani Rezvandeh R, Zare Ashrafi F, Shokouhian E, Edizadeh M, Booth KTA, et al. A Frameshift Variant in ANKRD24 Implicates Its Role in Human Non‐Syndromic Hearing Loss. Clinical Genetics. 2025. doi:10.1111/cge.14635
BibTeX
@article{Kazemi2025,
author = {Kazemi, Negar and Rezvani Rezvandeh, Raziye and Zare Ashrafi, Farzane and Shokouhian, Ebrahim and Edizadeh, Masoud and Booth, Kevin T A and Kahrizi, Kimia and Najmabadi, Hossein and Mohseni, Marzieh},
title = {A Frameshift Variant in ANKRD24 Implicates Its Role in Human Non‐Syndromic Hearing Loss},
journal = {Clinical Genetics},
year = {2025},
doi = {10.1111/cge.14635}
}
EUVIMED